JeffreyMooreTestaniMD
Cardiology • New Haven, CTAdult Congenital Heart Disease, Heart Failure & Transplantation
Assistant Professor, Internal Medicine, Yale University School of Medicine
Dr. Testani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St.
New Haven, CT 06520Phone+1 203-785-7191Fax+1 203-785-2917
Education & Training
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2007 - 2010- University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
University of Florida College of MedicineClass of 2004
Certifications & Licensure
CT State Medical License 2012 - 2026
PA State Medical License 2004 - 2012
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Clinical Trials
- A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure Start of enrollment: 2014 Jan 01
- Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure Start of enrollment: 2015 Aug 31
- Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects Start of enrollment: 2017 Jun 27
- Join now to see all
Publications & Presentations
PubMed
- Salt repletion and diuretic response: The role of serum chloride. A post-hoc analysis of the SALT-HF trial on furosemide and hypertonic saline solution administration ...Julio Núñez, Gema Miñana, Rafael de la Espriella, Isabel Zegrí-Reiriz, Josep Comín-Colet
European Journal of Heart Failure. 2025-02-11 - Reprieve System for the Treatment of Patients with Acute Decompensated Heart Failure.Juan B Ivey-Miranda, Veena S Rao, Tamaz Shaburishvili, Ivlita Verulava, Nina Khabeishvili
Journal of Cardiac Failure. 2025-02-04 - 1 citationsEffects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, Tazeen H Jafar, James L Januzzi
Journal of the American Society of Nephrology. 2025-02-01
Journal Articles
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
- Left Atrial Fibrosis Correlates with Extent of Left Ventricular Myocardial Delayed Enhancement and Left Ventricular Strain in Hypertrophic CardiomyopathyAlbert J Sinusas, Vinh Q Nguyen, Nikolaos Papoutsidakis, David J Hur, Jeffrey Testani, Hamid Mojibian, Judith L Meadows, Daniel Jacoby, Steffen Huber, The International Journal of Cardiovascular Imaging
- Enhancing the Prediction of Acute Kidney Injury Risk After Percutaneous Coronary Intervention Using Machine Learning Techniques: A Retrospective Cohort StudyFrederick A Masoudi, Karthik Murugiah, Julian S Haimovich, Wade L Schulz, John A Spertus, Harlan M Krumholz, Jeffrey M Testani, John S Rumsfeld, PLoS One
- Join now to see all
Authored Content
- Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's ExperienceAugust 2018
- Hemodynamic Factors Associated with Serum Chloride in Ambulatory Patients with Advanced Heart FailureDecember 2017
Press Mentions
Sequana Medical’s DSR 2.0 Outperforms Traditional Peritoneal Dialysis Solutions in StudyNovember 28th, 2024- Discoveries & Impact (July 2021)July 15th, 2021
- 2021 Yale Cardiovascular Medicine Fellowship GraduationMay 12th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
